Sol-Gel Technologies (SLGL) Long-Term Investments (2016 - 2025)

Sol-Gel Technologies (SLGL) reported Long-Term Investments of $1.3 million for Q4 2025, up 2.56% year-over-year from $1.3 million in Q4 2024, and up 2.56% quarter-over-quarter from $1.3 million in Q4 2024.

Sol-Gel Technologies (SLGL) Long-Term Investments (2016 - 2025) Analysis & Trends

Sol-Gel Technologies (SLGL) has 10 years of Long-Term Investments data on file, last reported at $1.3 million in Q4 2025.

  • Long-Term Investments for Q4 2025 came in at $1.3 million, up 2.56% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.3 million (up 2.56% YoY), and the FY2025 annual result was $1.3 million, up 2.56% from the prior year.
  • Long-Term Investments rose to $1.3 million in Q4 2025 per SLGL's latest filing, from $1.3 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $1.3 million in Q4 2025 and troughed at $12000.0 in Q2 2023.
  • A 5-year average of $1.2 million and a median of $1.3 million in 2021 frame the typical range for Long-Term Investments.
  • The sharpest annual moves came in 2023 and 2025: Long-Term Investments plunged 99.07% in 2023, then advanced 2.56% in 2025.
  • A 5-year view of Long-Term Investments shows it stood at $1.3 million in 2021, then dropped by 0.77% to $1.3 million in 2022, then retreated by 0.31% to $1.3 million in 2023, then rose by 0.55% to $1.3 million in 2024, then advanced by 2.56% to $1.3 million in 2025.
  • Business Quant data shows SLGL's Long-Term Investments at $1.3 million in Q4 2025, $1.3 million in Q4 2024, and $1.3 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.17 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Sol-Gel Technologies 207.80 Mn 197.67 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.32 Mn
Dec 31, 2024 1.29 Mn
Dec 31, 2023 1.28 Mn
Sep 30, 2023 1.29 Mn
Jun 30, 2023 12,000.00
Mar 31, 2023 1.30 Mn
Dec 31, 2022 1.29 Mn
Sep 30, 2022 1.29 Mn
Jun 30, 2022 1.29 Mn
Mar 31, 2022 1.30 Mn
Dec 31, 2021 1.30 Mn
Sep 30, 2021 1.29 Mn
Jun 30, 2021 1.29 Mn
Mar 31, 2021 1.29 Mn
Dec 31, 2020 1.29 Mn
Sep 30, 2020 1.29 Mn
Jun 30, 2020 1.28 Mn
Mar 31, 2020 1.27 Mn
Dec 31, 2019 472,000.00
Sep 30, 2019 471,000.00